UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 14A INFORMATION

 

 

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

Filed by the Registrant  
Filed by a Party other than the Registrant  

 

Check the appropriate box:

 

  Preliminary Proxy Statement
     
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
     
  Definitive Proxy Statement
     
  Definitive Additional Materials
     
  Soliciting Material Pursuant to § 240.14a-12

 

CorMedix Inc.

(Name of Registrant as Specified In Its Charter)

 

_________________________________________________________________

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

  No fee required
     
  Fee paid previously with preliminary materials.
     
  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11

 

 

 

 

 

 

 

 

 

 

 


CorMedix (NASDAQ:CRMD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CorMedix Charts.
CorMedix (NASDAQ:CRMD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CorMedix Charts.